Twist Bioscience Corporation (FRA:0ME)

Market Cap	2.37B +10.3%
Revenue (ttm)	333.49M +18.6%
Net Income	-65.23M
EPS	-1.08
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	55
Open	39.67
Previous Close	41.71
Day's Range	38.88 - 40.36
52-Week Range	20.36 - 47.47
Beta	n/a
RSI	49.00
Earnings Date	May 4, 2026

About Twist Bioscience

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Employees: 979
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 0ME

Financial Performance

In fiscal year 2025, Twist Bioscience's revenue was $376.57 million, an increase of 20.32% compared to the previous year's $312.97 million. Losses were -$77.67 million, -62.79% less than in 2024.

Financial numbers in USD